An international research team led by Prof. Dr. Sedat NizamoÄźlu from the Department of Electrical and Electronics Engineering ...
New research finds that retinal diseases thought to map one-to-one to genetic mutations are more complicated than that.
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...
After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than Genentech’s Vabysmo for patients with diabetic macular edema (DME) in an early ...
Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
Druggable Target to Treat Retinal Degeneration”Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: ...
Japan's Ministry of Health, Labour and Welfare (MHLW) grants MCO-010 Sakigake (Pioneering Regenerative Medical Product) and Orphan Drug designations, enabling an accelerated regulatory pathway for ...
Greenland sharks possess a DNA repair mechanism that maintains vision over centuries, preventing retinal degeneration despite extreme conditions. The sharks' visual system is well-adapted to dim light ...
Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.
Please provide your email address to receive an email when new articles are posted on . The incidence of diabetic eye disease continues to increase worldwide as diabetes remains a growing public ...